A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
Recruiting · Phase 3 · NCT03619850
Conditions: Chronic Kidney Disease, Iron Deficiency Anemia
At a glance
- Research payments reported, 2025
- $51,937
- U.S. investigators named
- 5
- Sites paid
- 6
- Planned or actual enrollment
- 129
About the trial
- Sponsor
- AMAG Pharmaceuticals, Inc.
- Tested
- Ferumoxytol (drug), Iron sucrose (drug)
- Dates
- Started 2018-08-13; completion 2026-08-31
- Results posted
- Not yet
Primary Objectives: To evaluate the safety (compared to iron sucrose) and efficacy of ferumoxytol in pediatric CKD subjects with iron deficiency anemia (IDA) or who are at risk of development of IDA Secondary Objective: To determine the single-dose pharmacokinetics (PK) and pharmacodynamics (PD) profile of ferumoxytol in pediatric subjects.
From ClinicalTrials.gov, last updated 2026-04-17. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Azurity Pharmaceuticals, Inc. reported $51,937 in research payments for this study in 2025 (25 payments).
Products named: Feraheme
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Alex Constantinescu, MD Pediatric Nephrology · Hollywood, FL
- Lilia Roque-guerrero, MD Pediatrics · Miami, FL
- Bradley A. Warady, MD Pediatric Nephrology · Kansas City, MO
- Oulimata Kane, M.D. Pediatric Nephrology · Akron, OH
- Christine B. Sethna, M.D. Pediatric Nephrology · Philadelphia, PA
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Bio Medical Research LLC $31,423
- The Feinstein Institutes for Medical Research $7,435
- Memorial Hospital West, FL $5,397
- Memorial Regional Hospital, FL $4,971
- $1,950
- The Children's Mercy Hospital, MO $460
- State of West Virgina $300
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.